SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-039902
Filing Date
2023-05-15
Accepted
2023-05-15 17:00:58
Documents
62
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0323_actiniumphar.htm   iXBRL 10-Q 757367
2 CERTIFICATION f10q0323ex31-1_actiniumphar.htm EX-31.1 9885
3 CERTIFICATION f10q0323ex31-2_actiniumphar.htm EX-31.2 9861
4 CERTIFICATION f10q0323ex32-1_actiniumphar.htm EX-32.1 3876
5 CERTIFICATION f10q0323ex32-2_actiniumphar.htm EX-32.2 3999
11 GRAPHIC img_001.jpg GRAPHIC 107444
12 GRAPHIC img_002.jpg GRAPHIC 75776
13 GRAPHIC img_003.jpg GRAPHIC 102316
14 GRAPHIC img_004.jpg GRAPHIC 109947
15 GRAPHIC img_005.jpg GRAPHIC 54781
16 GRAPHIC img_006.jpg GRAPHIC 93305
17 GRAPHIC img_007.jpg GRAPHIC 83065
18 GRAPHIC img_008.jpg GRAPHIC 54526
19 GRAPHIC img_009.jpg GRAPHIC 78582
20 GRAPHIC img_010.jpg GRAPHIC 44595
21 GRAPHIC img_011.jpg GRAPHIC 60287
22 GRAPHIC img_012.jpg GRAPHIC 79135
23 GRAPHIC img_013.jpg GRAPHIC 123469
  Complete submission text file 0001213900-23-039902.txt   6205378

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE atnm-20230331.xsd EX-101.SCH 39601
7 XBRL CALCULATION FILE atnm-20230331_cal.xml EX-101.CAL 23571
8 XBRL DEFINITION FILE atnm-20230331_def.xml EX-101.DEF 153701
9 XBRL LABEL FILE atnm-20230331_lab.xml EX-101.LAB 341812
10 XBRL PRESENTATION FILE atnm-20230331_pre.xml EX-101.PRE 170304
56 EXTRACTED XBRL INSTANCE DOCUMENT f10q0323_actiniumphar_htm.xml XML 251458
Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 23923954
SIC: 2834 Pharmaceutical Preparations